Duration of Doxycycline Treatment in MEM Patients
ConditionErythema Chronicum Migrans
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Medical Centre Ljubljana
About this trial
The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.
Eligibility criteria
Qualifiers
None
Disqualifiers
pregnancy or lactation
immunocompromised
serious adverse event to doxycycline
taking antibiotic with antiborrelial activity within 10 days
Trial design
Treatments tested in this trial
- Doxycycline 100 milligram Oral Tablet bid, 7 days
- Doxycycline 100 milligram Oral Tablet bid, 14 days
- Controls without a history of lyme disease.
Treatment groups
200 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov